2[2]Estadieu MC, Machou C, Berthexene P, et al. Balance sheet oftolerance-efficacy on the use of tacrine in 100 cases of Alzheimer, sdisease. Therapies 1998;53:67 -76
3[3]Canal N, Imbimbo B. for the Eptastigmine Study Group. Clinical trial and therapeutics: relationship betweenpharmacodynamic activity and cognirive effects ofeptatigmine in patients with Alzheimer, s disease. Clin Phamacol Ther 1996; 60:218
4[4]Trabace L, Coluccia A, Gaetaadi S, et al. In vivoneurochemical effect of the aoytelcholineterase inhibitor ENA-713 In rat hippocampus. Brain Res 2000; 865(2):268-71
5[5]Sugimoto H, Yanmishi Y, Limura Y, et al. Donepezil hycbocgloride(E2020) and other AchEIs Curr. Med Chem 2000; 7(3): 303 - 39
10[10]Tekin SC, Tanrinag T. Antiglutamatergictherapy in Alzheimer s disease effects of lamotrigine. Short communi-cation. J Neural Transm 1998: 105(2): 295 -303
5Luo L, Yano N, Mao Q, et al. Thyrotropin releasing hormone(TRH) in the hippocampus of Alzheimer patients. J Alzheimers Dis 2002; 4 (2): 97 - 103
6Kapaki E, Ilias I, Paraskevas GP, et al. Thyroid function in patients with Alzheimer's disease treated with cholinesterase inhibitors. Acta Neurobiol Exp (Wars) 2003; 63 (4): 389 - 92
7van Osch LA, Hogervorst E, Combrinck M, et al. Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease. Neurology 2004; 62 ( 11 ): 1967 - 71
8Kalmijn S, Mehta KM, Pols HA, et al. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol( Oxf)2000; 53 (6): 733 - 7
9Latasa MJ, Belandia B, Pascual A. Thyroid hormones regulate beta-amyloid gene splicing and protein secretion in neuroblastoma cells. Endocrinology 1998; 139(6): 2692 - 8
10Giovannini MG, Casamenti F, Nistri A, et al. Effect of thyrotropin releasing hormone(TRH) on acetylcholine release from different brain areas investigated by microdialysis. Br J Pharmacol 1991; 102(2): 363 - 8
